MMP9 and urinary bladder cancer: Nonetheless, these limitations do not diminish the relevance of this study, which provides novel insights into the potential of CRISPR/Cas9-mediated MMP-9 silencing as a promising strategy to impair bladder cancer cell migration and invasion in vitro, paving the way for future mechanistic and preclinical investigations.